Antigua and Barbuda vs Lithuania: Previously treated cases tested for RR-/MDR-TB
Antigua and Barbuda
100.0%
in 2022
Lithuania
100.0%
in 2024
Antigua and Barbuda rank
1st
Lithuania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Antigua and Barbuda
- Lithuania
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Lithuania, a difference of 0.0%.
Across all 5 years both countries report, Lithuania has been ahead every year.
Antigua and Barbuda ranks 1st and Lithuania ranks 1st of 180 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 100.0% | 50.0% | Lithuania |
| 2010s | 0.0% | 100.0% | 100.0% | Lithuania |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Antigua and Barbuda or Lithuania?
- Antigua and Barbuda, at 100.0% against 100.0% in Lithuania as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Antigua and Barbuda and Lithuania?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Lithuania?
- 5 years are reported by both, from 2009 to 2022.
- How do Antigua and Barbuda and Lithuania rank globally for previously treated cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and Lithuania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.